Patents
Patents for C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings (11,459)
11/2009
11/05/2009US20090274632 Identification of human T2R receptors that respond to bitter compounds that elicit the bitter taste in compositions, and the use thereof in assays to identify compounds that inhibit (block) bitter taste in composition and use thereof
11/05/2009CA2722733A1 Cyclopentylacrylamide derivative
11/05/2009CA2722704A1 Cyclylamine derivatives as calcium channel blockers
11/04/2009EP1784388B1 Biphenyloxyacetic acid derivatives for the treatment of respiratory disease
11/03/2009US7612092 Nitrogen-containing aromatic derivatives
11/03/2009CA2565660C Ortho substituted aryl or heteroaryl amide compounds
11/03/2009CA2443724C Novel, arylsusfonamide compounds for the treatment of obesity, type ii diabetes and cns-disorders
11/03/2009CA2383327C Thienoisoxazole phenoxy unsubstituted ethyl and propyl derivatives useful as d4 antagonists
10/2009
10/29/2009WO2009131951A2 Compounds, compositions and methods comprising isoxazole derivatives
10/29/2009WO2009130264A1 PROCESS FOR PREPARING A CRYSTALLINE FORM COMPOUND OF 3-BENZYL-2-METHYL-2,3,3a,4,5,6,7,7a-OCTAHYDROBENZO[d]ISOXAZOL-4-ONE
10/29/2009WO2009130263A1 PROCESS FOR PREPARING A CRYSTALLINE FORM COMPOUND OF 3-BENZYL-2-METHYL-2,3,3a,4,5,6,7,7a-OCTAHYDROBENZO[d]ISOXAZOL-4-ONE
10/29/2009CA2720818A1 Substituted phenoxybenzamides
10/28/2009EP2112142A1 Process for preparing a crystalline form compound of 3-benzyl-2-methyl-2,3,3a,4,5,6,7,7a-octahydrobenzo[d]isoxazol-4-one
10/27/2009US7608739 2,3-Dihydrooxadiazoles such as 3-acetyl-5-(2,5-difluorophenyl)-2-phenyl-2,3-dihydro-1,3,4-oxadiazole and 3-[3-acetyl-5-(2,5-difluorophenyl)-2-phenyl-2,3-dihydro-1,3,4-oxadiazol-2-yl]-N,N-dimethylpropan-1-amine that are useful for treating cancer
10/27/2009US7608631 1-(4-{3-[2,6-Dichloro-4-(3,3-dichloro-allyloxy)-phenoxy]-propoxy}-phenyl)-1H-pyrrole, for example; protecting soybean plants against pests such as caterpillars
10/27/2009US7608564 Herbicide; in crops such as wheat, rice, maize, soybeans and cotton they act against broad-leaved weeds and grass weeds without damaging the crop plants; compounds are based on 3-(5,5-disubstituted 2-isoxazolin-3-yl)benzoic acid, esters, thioesters and pyrazolyl ketones thereof
10/22/2009WO2009127338A1 Oxo-heterocyclic substituted carboxylic acid derivates and the use thereof
10/22/2009US20090264486 Compounds, Compositions and Methods Comprising Isoxazole Derivatives
10/21/2009EP2109602A2 Tetracycline derivatives for the treatment of bacterial, viral and parasitic infections
10/21/2009CN101559053A 5-membered heterocycle derivatives, production thereof and use thereof as medicaments
10/20/2009US7605164 Compositions and methods for treating heart failure
10/20/2009US7605150 Drug therapy for Celiac Sprue
10/20/2009CA2585898C Use of (2s,3s,5s)-5-(n-(n-((n-methyl-n-((2-isopropyl-4-thaizolyl)methyl)amino)-carbonyl)valinyl)amino)-2-(n-((5-thiazolyl)methoxycarbonyl)amino)-1,6-diphenyl-3-hydroxyhexane in combination with another protease inhibitor for treating hiv infection
10/20/2009CA2441798C Crystalline isoxazole derivative and medical preparation thereof
10/15/2009WO2009126668A2 Method for preparing 3-trifluoromethyl chalcones
10/15/2009WO2008145615A3 Aminoazoline and urea derivatives for combating animal pests
10/15/2009WO2008115149A9 N-HETEROCYCLIC CARBENE CATALYZED SYNTHESIS OF N-PHENYLISOXAZOLIDIN-5-ONE DERIVATIVE AND SYNTHESIS OF β -AMINO ACID ESTER DERIVATIVE
10/15/2009US20090258884 Substituted amides
10/15/2009US20090258868 Heterocyclic aspartyl protease inhibitors
10/15/2009CA2720530A1 Sulfonamides
10/15/2009CA2718668A1 Method for preparing 3-trifluoromethyl chalcones
10/14/2009EP1720829B1 Derivatives of heteroaryl-alkylcarbamates, preparation method thereof and use of same as faah enzyme inhibitors
10/14/2009EP1658267B1 Inhibitors of cathepsin s
10/14/2009CN100549003C 3-aminophenol derivatives and dyes that contain these compounds while serving to dye keratin fibers
10/13/2009US7601674 α-oxygenated or α-thiolated carboxylic acid phenethylamide derivatives
10/08/2009WO2009123241A1 Inhibitor of plasminogen activator inhibitor-1
10/08/2009WO2009122034A2 Novel hsp90 inhibitory carbazole derivatives, compositions containing same, and use thereof
10/08/2009US20090253659 Cycloalkylidene Compounds As Modulators of Estrogen Receptor
10/08/2009US20090253656 Bcrp/abcg2 inhibitor
10/08/2009CA2718488A1 Novel dhsp90 inhibitory carbazole derivatives, compositions containing same, and use thereof
10/07/2009EP2107052A1 Novel n-(2-aminophenyl)benzamide derivative having an urea structure
10/06/2009US7598412 Cystic fibrosis transmembrane conductance regulator; ABC transporter mediated diseases like cystic fibrosis; 5-methoxy-N-((1-(3,4-dimethoxyphenyl)-cyclohexyl)methyl)benzofuran-2-carboxamide; or sulfonamide analogs; chloride or bicarbonate channel modulators
10/06/2009US7598391 Heteroaryl-ureas and their use as glucokinase activators
10/06/2009US7598389 Silylated carboxamides
10/06/2009US7598283 Controlling cell proliferation, cell differentiation,autoimmune disease; N-[4-(3-amino-1,2-benzisoxazol-4-yl)phenyl]-N'-(3-methylphenyl)urea; 2-[4-(3-amino-1H-indazol-4-yl)phenyl]-N-(3-chlorophenyl)acetamide; N-[4-(3-amino-1,2-benzisothiazol-4-yl)phenyl]-N'-(3,5-dimethylphenyl)urea; anticarcinogenic
10/06/2009US7598280 For the treatment, prevention and management of inflammatory and autoimmune diseases and disorders; for example, (1R,2S,3R)-1-(2-(5-methylisoxazol-3-yl)-1H-imidazol-5-yl)butane-1,2,3,4-tetraol
10/06/2009US7598236 Diazabicyclic central nervous system active agents
10/06/2009CA2301377C N-aroylphenylalanine derivatives
10/01/2009WO2009119652A1 USE OF BENZOPHENONE DERIVATIVE OR SALT THEREOF AND TNF α INHIBITOR IN COMBINATION AND PHARMACEUTICAL COMPOSITION CONTAINING THE DERIVATIVE OR SALT THEREOF AND THE INHIBITOR
10/01/2009WO2009118125A1 4-(3-aminobenzoyl)-5-cyclopropylisoxazoles effective as herbicides
10/01/2009US20090247547 Hydroxamate-based inhibitors of deacetylases b
10/01/2009US20090247509 for treating central nervous system disorders such as psychological disorders, drug dependence and abuse, dyskinesia, dementia, anxiety disorders, sleep disorders and mood disorders
10/01/2009CA2719533A1 4-(3-aminobenzoyl)-5-cyclopropylisoxazoles effective as herbicides
10/01/2009CA2719290A1 Use of benzophenone derivative or salt thereof and tnf.alpha. inhibitor in combination and pharmaceutical composition containing the derivative or salt thereof and the inhibitor
09/2009
09/30/2009EP2105437A1 4-(3-Aminobenzoyl)-5-cyclopropylisoxazols as herbicides
09/30/2009EP2105435A1 Hydrazone derivative
09/30/2009EP2104664A1 Tetrahydrobenzoisoxazole - and tetrahydroindazole derivatives as modulators of the mitotic motor protein
09/30/2009EP1501361B1 3-heteroaryl substituted 5-methyloxymethyl isoxazolines used as herbicides
09/29/2009US7595332 Such as N-(4-tert-butylphenyl)-4-(2-pyridinyl)benzamide for treatment of urinary incontinence, pain, inflammatory thermal hyperalgesia, and/or bladder overactivity
09/29/2009US7595309 For therapy of bacterial infections and neoplasms,
09/29/2009US7595162 Methods of labeling polynucleotides with energy transfer dyes
09/24/2009WO2009076454A3 Compounds that modulate intracellular calcium
09/24/2009WO2009035949A3 Soluble epoxide hydrolase inhibitors
09/24/2009US20090239798 Compounds, Methods and Formulations for the Oral Delivery of a Glucagon-Like Peptide (Glp)-1 Compound or a Melanocortin-4 Receptor (Mc4) Agonist Peptide
09/23/2009EP2102155A1 Aryl compounds as ppar ligands and their use
09/23/2009EP1377288B1 2,1-oxazoline and 1,2-pyrazoline-based inhibitors of dipeptidyl peptidase iv and use
09/23/2009CN101538230A Beta-amino ketones compound with anti-diabetic activity
09/23/2009CN100543017C Novel keto-oxadiazole derivatives as cathepsin inhibitors
09/22/2009US7592456 Arylsulfonylnaphthalene derivatives as 5HT2A antagonists
09/22/2009US7592354 Administering a stimulantfor the endogenous production/ release of somatotropins; 3-((1-(2-aminoprop-2-yl)carbonylamino-),2-(phenylmethoxymethyl-)ethyl-),5-(morpholino-carbonyloxymethyl-)-5,6,7,8-tetrahydro-1,2,4-triazolo(4,3-)pyridine; osteoporosis; obesity;improving bone densisty, muscle mass/strength
09/17/2009WO2009112275A1 Pesticidal condensed - ring aryl compounds
09/17/2009US20090233975 Hair resiliency/body improver and hair cosmetic
09/17/2009US20090233915 mitogen-activated protein kinase inhibitors such as 3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-N-(2-hydroxy-ethoxy)-5(2-hydroxy-ethoxymethyl)-benzamide, used to treat proliferative diseases, for example, cancers, psoriasis, restenosis, autoimmune diseases and atherosclerosis
09/17/2009CA2718199A1 Pesticidal condensed-ring aryl compounds
09/16/2009EP2100605A1 Bis(thio-hydrazide amide) compounds in combination with taxol for treating cancer
09/16/2009EP1581488B1 Inhibitors of tace
09/16/2009EP1478364B1 Selective antibacterial agents
09/16/2009CN101535282A A salt of 3-benzyl-2-methyl-2,3,3a,4,5,6,7,7a-octahydrobenzo[d]isoxazol-4-one
09/16/2009CN101535281A A salt of 3-benzyl-2-methyl-2,3,3a,4,5,6,7,7a-octahydrobenzo[d]isoxazol-4-one
09/16/2009CN100540534C N-alkynyl-2- (substituted aryloxy) alkylthioamide derivatives as fungicides
09/15/2009US7589232 5-[(3-Cyclopentylpropanoyl)(4-dec-1-ynylbenzyl)amino]-2-hydroxybenzoic acid; inflammatory disorder, obesity and/or metabolic disorders mediated by insulin resistance or hyperglycemia, comprising diabetes, inadequate glucose tolerance, insulin resistance, hyperlipidemia, hypertriglycerimia
09/15/2009US7589207 Chemokine receptors; inhibition of HIV replication; acquired immune deficiency syndrome (AIDS); cis N-(4-{2-[3-(2-methyl-1H-benzimidazol-1-yl)-8-azabicyclo[3.2.1]oct-8-yl]ethyl}-4-phenylcyclohexyl)-1H-pyrazole-4-carboxamide
09/15/2009US7589102 Heterocyclic aromatic compounds useful as growth hormone secretagogues
09/15/2009US7589094 N- (3-amino-2-hydroxy-propyl) substituted alkylamide compounds
09/15/2009US7589089 Inhibitors for GlyT-1
09/15/2009CA2429220C Gaba enhancers in the treatment of diseases relating to reduced neurosteroid activity
09/11/2009WO2009111447A2 Isosorbide derivatives and their use as flavor modifiers, tastants, and taste enhancers
09/11/2009CA2716741A1 Isosorbide derivatives and their use as flavor modifiers, tastants, and taste enhancers
09/10/2009US20090227790 A kit for treating a disorder characterized by loss of dopaminergic and/or motoneurons, for treating Parkinson's disease, amyotrophic lateral sclerosis (ALS), or limiting damage to neuronal cells by Parkinsonian conditions
09/10/2009US20090227645 Pharmaceutical compositions of valdecoxib
09/10/2009US20090227604 Vitamin d receptor modulators
09/10/2009US20090227592 Compounds effecting glucokinase
09/09/2009EP2098517A1 Novel phenyl-isoxazol-3-ol derivative
09/09/2009EP2097396A2 Process for the preparation of 5-hydroxyisoxazolidines, 5-isoxazolidinones, b-amino acids, b-amino aldehydes and derivatives thereof
09/09/2009EP2097380A1 New haloalkylsulfone substituted compounds useful for treating obesity and diabetes
09/09/2009CN101528716A Compounds and methods for inhibiting the interaction of BCL proteins with binding partners
09/09/2009CN100537527C Aryl and biaryl compounds having MCH modulatory activity
09/08/2009US7585859 PDE4B inhibitors and uses therefor
09/03/2009WO2009105906A1 Flavor molecules
09/03/2009WO2009068171A3 Chiral 3-(benzylsulfinyl)-5,5-dimethyl-4,5-dihydroisoxazole derivatives and 5,5-dimethyl-3-[(1h-pyrazol-4-ylmethyl)sulfinyl]-4,5-dihydroisoxazole derivatives, method for the production thereof, and use of same as herbicides and plant growth regulators
1 ... 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 ... 115